SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -97.6% | 616 | -98.2% | 0.00% | – |
| Q1 2022 | $41,000 | -63.1% | 34,216 | +0.4% | 0.00% | – |
| Q4 2021 | $111,000 | -27.5% | 34,077 | -0.6% | 0.00% | – |
| Q3 2021 | $153,000 | -17.3% | 34,280 | +0.8% | 0.00% | – |
| Q2 2021 | $185,000 | -26.3% | 34,009 | +1.2% | 0.00% | – |
| Q1 2021 | $251,000 | -20.6% | 33,600 | +15.5% | 0.00% | – |
| Q4 2020 | $316,000 | -11.5% | 29,100 | -28.0% | 0.00% | – |
| Q3 2020 | $357,000 | -17.2% | 40,400 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $431,000 | +131.7% | 40,400 | +29.1% | 0.00% | – |
| Q1 2020 | $186,000 | -13.5% | 31,300 | +0.6% | 0.00% | – |
| Q4 2019 | $215,000 | -41.3% | 31,100 | -11.9% | 0.00% | – |
| Q3 2019 | $366,000 | +11.9% | 35,300 | 0.0% | 0.00% | – |
| Q2 2019 | $327,000 | +31.9% | 35,300 | +30.3% | 0.00% | – |
| Q1 2019 | $248,000 | +64.2% | 27,100 | 0.0% | 0.00% | – |
| Q4 2018 | $151,000 | -53.3% | 27,100 | 0.0% | 0.00% | – |
| Q3 2018 | $323,000 | +16.6% | 27,100 | 0.0% | 0.00% | – |
| Q2 2018 | $277,000 | +59.2% | 27,100 | +102.2% | 0.00% | – |
| Q1 2018 | $174,000 | +33.8% | 13,400 | 0.0% | 0.00% | – |
| Q4 2017 | $130,000 | -34.0% | 13,400 | 0.0% | 0.00% | – |
| Q3 2017 | $197,000 | -8.8% | 13,400 | 0.0% | 0.00% | – |
| Q2 2017 | $216,000 | +170.0% | 13,400 | +167.9% | 0.00% | – |
| Q1 2017 | $80,000 | +31.1% | 5,001 | +0.0% | 0.00% | – |
| Q4 2016 | $61,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |